CURRENT NEWS

• 14.12.2018
  Leap Therapeutics Presents TRX518 Data at ESMO Immuno-Oncology Congress 2018 and Updated Data from DKN-01 Study in Biliary Tract Cancer
• 14.12.2018
  Bellicum Reports Safety Results and Promising Activity of Its Controlled CAR-T Candidate BPX-601 in Patients with Advanced Pancreatic Cancer at ESMO-IO
• 14.12.2018
  Idera Pharmaceuticals Presents Clinical Safety and Efficacy Update from the ILLUMINATE-204 Trial of the Combination of Tilsotolimod and Ipilimumab for Unresectable or Metastatic Melanoma Following Failure of PD-1 Inhibitor Treatment
• 14.12.2018
  Axovant Sciences Announces Pricing of $30 Million Public Offering of Common Shares
• 14.12.2018
  Generex Biotechnology Partner Regentys Corporation Receives European Patent Approval for ECMH for Treatment of Ulcerative Colitis
• 14.12.2018
  Sensorion Announces Positive Topline Results from Seliforant Phase 2a Study
• 14.12.2018
  Genmab Announces Submission of Supplemental New Drug Application for Daratumumab in Front Line Multiple Myeloma in Japan
• 14.12.2018
  Zealand Pharma Increases Its Share Capital as a Consequence of Exercise of Employee Warrants
• 14.12.2018
  Santhera Raises Gross Proceeds of CHF 23.5 Million and Secures Acquisition of Option to Vamorolone Sub-License
• 14.12.2018
  Santhera Provides Update on the Share Placement
• 14.12.2018
  RaQualia Pharma Joins DeNA & DeNA Life Science AI-Powered Drug Discovery Research Collaboration
• 14.12.2018
  BioArctic Outlicenses Its Alpha-Synuclein Antibody Portfolio for Parkinson's Disease to AbbVie After Receiving Clearance
• 14.12.2018
  Notification of the Results of Phase III Clinical Study in Opioid Analgesic NaïVe Patients of the Transdermal, Pain Management Patch FENTOSTAPE (Development Code:HFT-290)
• 14.12.2018
  12-Month Results From Study Of NeoTract's UroLift System For BPH In Men With An Obstructive Median Lobe Published In Prostate Cancer And Prostatic Diseases
• 14.12.2018
  Innovus Pharma Announces All Cash Acquisition of All of the Assets of SupplementHunt.Com, an E-Commerce Store with Its Proprietary Sales Platform and Marketing Technology
• 14.12.2018
  Leap Therapeutics Presents TRX518 Data at ESMO Immuno-Oncology Congress 2018 and Updated Data from DKN-01 Study in Biliary Tract Cancer
• 14.12.2018
  Glenmark Pharmaceuticals Announces New Data on GBR 1302, a HER2xCD3 Bispecific Antibody, Presented at the ESMO Immuno-Oncology Congress 2018
• 14.12.2018
  Astellas Acquires Potenza Therapeutics - Acquisition Adds Clinical Stage Novel Immuno-Oncology Programs to Astellas' Oncology Pipeline
• 14.12.2018
  Vargatef Plus Docetaxel Could Be an Option After Failure of Immunotherapy in Lung Cancer
• 14.12.2018
  KalVista Pharmaceuticals Reports Fiscal Second Quarter Results

Records per page:

Page

Total: 36219 records.